title: End of the bare metal stent era?
abstract: Second-generation drug eluting stents (2g-DES) have lower rates of stent thrombosis (ST) than bare metal stents (BMS). Second-generation DES have exceedingly low rates of very late ST, significantly improving on first-generation drug eluting stents (1g-DES) and similar to BMS. Emerging drug-coated stent (DCS) technology appears superior to BMS in patients unable to tolerate prolonged dual antiplatelet therapy (DAPT).
authors.affiliation: Heart South Cardiovascular Group and Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: William B
authors.initials: WB
authors.lastname: Hillegass
mesh_terms: D054855:Drug-Eluting Stents; D006801:Humans; D008670:Metals; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D008670:Metals